NI
72
4
VRSN
53
-5
EL
15
-3
ISRG
71
-5
STT
64
2
FE
44
5
GIS
22
-4
HUM
41
-4
ACN
47
-5
ROP
53
-9
AON
54
2
THC
60
-5
MUR
44
-3
MTB
65
-2
UAL
83
-2
DTE
43
5
TXT
53
-3
DLTR
38
-4
SYY
49
9
DOV
65
-4
NI
72
4
VRSN
53
-5
EL
15
-3
ISRG
71
-5
STT
64
2
FE
44
5
GIS
22
-4
HUM
41
-4
ACN
47
-5
ROP
53
-9
AON
54
2
THC
60
-5
MUR
44
-3
MTB
65
-2
UAL
83
-2
DTE
43
5
TXT
53
-3
DLTR
38
-4
SYY
49
9
DOV
65
-4
Financhill
Back

Canadian Pacific Kansas City Vs. Neurogene Industry Stock Comparison

Sell
33

CP.TO
Canadian Pacific Kansas City

Last Price:
104.29
Seasonality Move:
4.97%
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Sell
33
Canadian Pacific Kansas City (CP.TO) is a Sell

Is Canadian Pacific Kansas City a Buy, Sell or Hold?

  • The current Canadian Pacific Kansas City [CP.TO] share price is $104.29. The Score for CP.TO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • CP.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CP.TO Stock Price Chart

What is Canadian Pacific Kansas City's stock price today?

  • The Canadian Pacific Kansas City share price today is $104.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CP.TO is experiencing selling pressure, which indicates risk of future bearish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

CP.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.4 Sell
Relative Strength Index (14 RSI): 29.3 Sell
Chaikin Money Flow: -1672623 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (106.9 - 110.88) Sell
Bollinger Bands (100): (107.89 - 114.55) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

CP.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 107.41 Sell
20-day SMA: 108.11 Sell
50-day SMA: 111.79 Sell
200-day SMA: 112.5 Sell
8-day EMA: 106.87 Sell
20-day EMA: 108.29 Sell
50-day EMA: 110.06 Sell
200-day EMA: 110.34 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

Canadian Pacific Kansas City Earnings Growth & CP.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and an increase next year of $0.77 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Canadian Pacific Kansas City Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):